Physician profile

James Muth

Clinical Cardiac Electrophysiology · Lawrenceburg, IN

NPI 1750586483

$48,364.10

in general payments reported to CMS, 2019-2025

34 companies · $4,484 in 2025

The $4,484 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,242.92
Travel and Lodging$4,379.37
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$4,000.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Biotronik INC. $22,979.54 2019-2024 Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge
Medtronic Vascular, INC. $9,819.75 2019-2020
Boston Scientific Corporation $7,424.25 2020-2025 Farapulse, Watchman Access System, General - Therapies
Medtronic, INC. $1,859.38 2021-2025 Pulseselect, Affera Mapping System, Cobalt Dr Mri Surescan
Medical Device Business Services, INC. $1,407.02 2024 Carto 3
Biosense Webster, INC. $1,223.84 2021-2025 Carto 3, Nuvision Ice Catheter
Abbott Laboratories $955.40 2020-2025 Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit, Aveir
Impulse Dynamics (USA) INC. $516.18 2020-2025 Optimizer
Zoll Respicardia, INC. $507.60 2019
Atricure, INC. $185.96 2021
Esperion Therapeutics, INC. $153.37 2021-2024 Nexletol
Cardiva Medical, INC. $151.65 2020-2024 Cardiva Vascade Mvp Vvcs 6-12f
Braemar Manufacturing, LLC $151.34 2019
Cvrx, INC. $144.99 2021
Pfizer INC. $134.86 2024-2025
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $110.49 2023-2025 Verquvo, Winrevair
Janssen Pharmaceuticals, INC $89.32 2021-2024 Xarelto
Philips North America LLC $79.03 2020
Amgen INC. $72.44 2021-2025 Repatha, Repatha
Bayer Healthcare Pharmaceuticals INC. $56.36 2024-2025
Novartis Pharmaceuticals Corporation $48.04 2023-2025
E.R. Squibb & Sons, L.L.C. $46.50 2024-2025 Camzyos, Eliquis
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $34.27 2022-2025 Lifevest
Boehringer Ingelheim Pharmaceuticals, INC. $33.02 2024-2025 Jardiance
Veryan Medical Incorporated $30.03 2021
Scpharmaceuticals INC. $20.97 2025
Lexicon Pharmaceuticals, INC. $17.15 2024
Edwards Lifesciences Corporation $16.94 2024 Sapien 3 Ultra Resilia
Novo Nordisk INC $16.77 2025 Rybelsus, Ozempic
Actelion Pharmaceuticals US, INC. $16.21 2024 Opsumit
Kiniksa Pharmaceuticals International, Plc $15.86 2024 Arcalyst
Vital Connect, INC $15.69 2025 Vitalpatch Rtm
Stryker Corporation $15.47 2023 Prevalon
Glaxosmithkline, LLC. $14.41 2025 Arexvy, Shingrix

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James Muth

$48,364.10

in general payments reported 2019-2025

Years
2019-2025
Top company
Biotronik INC.
Context
The $4,484 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/34066/james-muth

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.